FDA MAP
  • Home
  • Workshops
  • WEBINARS
  • Regulatory Services
  • Quality Assurance
  • Custom Training
Newsletter - October 5 2017
​
California Does What FDA Can’t: Require Unapproved Stem Cell Clinics to Inform Patients

 ​
California passed a law this week that requires physicians providing unapproved stem cell therapies to prominently display at multiple locations within the clinic that the stem cell therapy provided by them is not approved by FDA. The intent of the new law is to assure that patients are aware of the unapproved status of the so-called treatment, and can make educated decisions. Read More

FDA Relaxes eCTD Format to Give More Flexibility to Applicants 


In a new guidance released this week FDA revised the CTD and eCTD formats of market approval applications for drugs and biologics (NDA, ANDA and BLA) with the intent to simplify the documents and provide higher flexibility for organizing content. FDA also withdrew two previous guidance documents.. Read More

Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions 
  • Certification Program
  • Smart Recruitment

Company

  • About Us
  • Our Instructors
  • Testimonials
  • Free Resources
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2015 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.
✕